XOMA Ltd. Bermuda (XOMA)

SHARE
TEXT SIZE:
SHARE
Send a copy to me

Separate multiple email addresses (max 20) with commas.

0/1500
Steven B. Engle , President/CEO/Director/Chairman of the Board
Industry: Healthcare
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME


Overview
News
People
Financials

Company Information

Steven B. Engle, President/CEO/Director/Chairman of the Board

2910 Seventh Street

Berkeley, CA 94710

US Map it

Phone: (510) 204-7200

Fax: (510) 644-0537

www.xoma.com



Overview

A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.

Employees

Number of Employees: 311
Revenue per Employee: $308,059

Financials

Quarterly
Annual

Income Statement 08/2008 05/2008 03/2008 11/2007
Sales -1.34 Mil. -1.93 Mil. -2.15 Mil. -1.1 Mil.
Gross Operating Profit 12.45 Mil. 13.99 Mil. 16.88 Mil. 44.24 Mil.
Operating Income before D & A (EBITDA) -17.45 Mil. -11.1 Mil. -6.99 Mil. 23.82 Mil.
Total Income Before Interest Expenses (EBIT) -18.53 Mil. -12.72 Mil. -8.65 Mil. 23.06 Mil.
Total Net Income -20.69 Mil. -14.18 Mil. -9.88 Mil. 21.82 Mil.
Basic EPS, Total -0.16 -0.11 -0.08 0.17
Diluted EPS, Total -0.16 -0.11 -0.08 0.16

BALANCE STATEMENT 08/2008 05/2008 03/2008 11/2007
Cash and Equivalents 20.73 Mil. 8.82 Mil. 22.5 Mil. 41.77 Mil.
Total Assets 49.94 Mil. 29.32 Mil. 58.09 Mil. 64.79 Mil.
Total Liabilities 24.63 Mil. 16.94 Mil. 23.6 Mil. 21.14 Mil.
Total Capitalization -30.49 Mil. 30.49 Mil. 318 K. 9.25 Mil.

Cash Flow 08/2008 05/2008 03/2008 11/2007
Net Cash From Continuing Operations -26.42 Mil. -14.37 Mil. 4.54 Mil. 7.39 Mil.
Net Cash From Investing Activities 1.79 Mil. 8.77 Mil. -8.83 Mil. 8.7 Mil.
Net Cash From Financing Activities 22.86 Mil. -8.08 Mil. -1.21 Mil. -2.32 Mil.
Net Change in Cash & Cash Equivalents -1.77 Mil. -13.68 Mil. -5.5 Mil. 13.77 Mil.

powered by Interactive Data

Income Statement 2008 2007 2006 2005
Sales -6.73 Mil. -6.17 Mil. -5.77 Mil. -4.55 Mil.
Gross Operating Profit 90.99 Mil. 35.67 Mil. 24.44 Mil. 8.22 Mil.
Operating Income before D & A (EBITDA) 4.19 Mil. -34.51 Mil. -30.25 Mil. -73.54 Mil.
Total Income Before Interest Expenses (EBIT) -741 K. -38.91 Mil. 7.04 Mil. -77.71 Mil.
Total Net Income -12.33 Mil. -51.84 Mil. 2.78 Mil. -78.94 Mil.
Basic EPS, Total -0.1 -0.54 0.03 -0.93
Diluted EPS, Total -0.1 -0.54 0.03 -0.93

BALANCE STATEMENT 2008 2007 2006 2005
Cash and Equivalents 22.5 Mil. 28 Mil. 20.8 Mil. 23.81 Mil.
Total Assets 58.09 Mil. 65.89 Mil. 50.29 Mil. 26.61 Mil.
Total Liabilities 23.6 Mil. 22.67 Mil. 16.54 Mil. 23.6 Mil.
Total Capitalization 318 K. 8.65 Mil. 39.33 Mil. -24.61 Mil.

Cash Flow 2008 2007 2006 2005
Net Cash From Continuing Operations 4.54 Mil. -33.27 Mil. -44.19 Mil. -44.83 Mil.
Net Cash From Investing Activities -8.83 Mil. -8.44 Mil. -27.38 Mil. -2.64 Mil.
Net Cash From Financing Activities -1.21 Mil. 48.91 Mil. 68.57 Mil. -13.54 Mil.
Net Change in Cash & Cash Equivalents -5.5 Mil. 7.2 Mil. -3 Mil. -61 Mil.

powered by Interactive Data







Related Companies by Market Cap
Company Name
Price
Change
Market Cap
356.47 Mil.
354.72 Mil.
369.04 Mil.
371.51 Mil.

Company Profile Change Request

The data provided in our company profiles comes from third party information providers.

Also in Portfolio.com
Most Read
Most Emailed
Recently Commented

Newsletter Sign-Up
Subscribe
Newsletter Sign-Up
Subscribe